AI predicts cancer patient survival by reading doctor’s notes
Predicting cancer survival is an important factor that can be used to improve cancer care.
Research by UBC professor lays groundwork for life-saving breast cancer treatment
Drug promotes disease-free survival in breast cancer patients and markedly improves quality of life
UBC biotech spin-off raises $75M to bring cancer treatments to patients
With roots in UBC research, Alpha-9 Theranostics is developing cancer radiotherapies that target tumours while avoiding healthy tissues.
UBC researchers develop an improved hereditary cancer test
The new test is the first to be able to determine which parent a cancer predisposing gene came from, promising to improve familial testing strategies.
One in seven billion: First-in-the-world diagnosis a result of incredible teamwork
Researchers at UBC and BCCHRI uncovered a never-before-seen diagnosis for a young Syrian refugee facing reduced mobility and recurring cancers.
Single-cell genome sequencing provides new insights into deadly cancers
New research into the most aggressive forms of breast and ovarian cancer shines light on how tumours evolve.
A team approach to understanding post-treatment cancer care
Researchers at UBCO are exploring the critical role family physicians play in post-cancer care.
Artificial intelligence enhances ovarian cancer diagnostics
New AI technology developed by UBC researchers could improve diagnostics in remote communities that lack available specialists.
UBC researchers part of international collaboration to develop treatments for osteosarcoma
The team developed new tools to understand how the cancerous cells spread and survive throughout the body.
With just a tablespoon of blood, B.C. researchers aim to transform cancer treatment
The researchers have developed a new blood test that sequences the genome of tumour DNA in the blood, opening up new possibilities for personalized medicine.